Literature DB >> 27287684

Are perinatal outcomes affected by blastocyst vitrification and warming?

Maya Barsky1, Peter St Marie2, Tayyab Rahil2, Glenn R Markenson2, Cynthia K Sites2.   

Abstract

BACKGROUND: Transfer of cryopreserved-warmed embryos into an appropriately prepared uterus unaffected by controlled ovarian hyperstimulation is common in the practice of in vitro fertilization. There is limited information on the effect of blastocyst vitrification and warming on perinatal outcomes.
OBJECTIVE: We sought to determine if perinatal outcomes are affected after the transfer of vitrified-warmed blastocysts compared to the transfer of fresh blastocysts, by comparing preeclampsia rate, birthweight, percentage of low birthweight, and preterm delivery rate between embryo transfer types. STUDY
DESIGN: We performed a retrospective database cohort study of 289 fresh and 109 vitrified-warmed blastocyst transfer cycles at an academic medical center. Cycles were performed from July 2, 2009, through Dec. 8, 2014, and included infants born at ≥20 weeks gestational age, excluding donor egg cycles. We examined the association between transfer type (fresh or vitrified-warmed) and proportion of deliveries complicated by preeclampsia, preterm delivery (gestational age <37 weeks), and low birthweight (<2500 g). We assessed associations using generalized linear models, both unadjusted and adjusted, for maternal age, newborn sex, diabetes status, and parity.
RESULTS: We observed more pregnancies complicated by preeclampsia following vitrified-warmed transfers (7.6%) compared to fresh embryo transfers (2.6%) (P = .023) (adjusted odds ratio, 3.1; 95% confidence interval, 1.2-8.4). Newborns resulting from vitrified-warmed embryo transfer cycles were similar to those resulting from fresh embryo transfer cycles with regard to low birthweight (7.4% vs 5.3%, P = .421), mean birthweight (3443 vs 3431 g, P = .865), and preterm delivery rate (9.2% vs 8.7%, P = .869).
CONCLUSION: We conclude that embryo vitrification with warming may affect some perinatal outcomes since preeclampsia is increased compared to fresh blastocyst transfer. However, other perinatal outcomes such as low birthweight and preterm delivery rate are not affected. Fresh blastocyst transfers should be considered when possible as they may reduce the incidence of preeclampsia.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  assisted reproductive technology; embryo cryopreservation; in vitro fertilization; perinatal outcomes; preeclampsia; vitrification

Mesh:

Year:  2016        PMID: 27287684     DOI: 10.1016/j.ajog.2016.06.002

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Evidence for Corpus Luteal and Endometrial Origins of Adverse Pregnancy Outcomes in Women Conceiving with or Without Assisted Reproduction.

Authors:  Kirk P Conrad
Journal:  Obstet Gynecol Clin North Am       Date:  2020-03       Impact factor: 2.844

Review 2.  Comparison of pregnancy outcomes after vitrification at the cleavage and blastocyst stage: a meta-analysis.

Authors:  MeiFang Zeng; SuQin Su; LiuMing Li
Journal:  J Assist Reprod Genet       Date:  2017-09-22       Impact factor: 3.412

3.  Risk of ischemic placental disease in fresh and frozen embryo transfer cycles.

Authors:  Katherine M Johnson; Michele R Hacker; Nina Resetkova; Barbara O'Brien; Anna M Modest
Journal:  Fertil Steril       Date:  2019-02-28       Impact factor: 7.329

4.  Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data.

Authors:  Bo Yu; Mario Vega; Sahar Zaghi; Rani Fritz; Sangita Jindal; Erkan Buyuk
Journal:  J Assist Reprod Genet       Date:  2018-08-20       Impact factor: 3.412

5.  Abnormal implantation after fresh and frozen in vitro fertilization cycles.

Authors:  Erica T Wang; Anupama S Q Kathiresan; Catherine Bresee; Naomi Greene; Carolyn Alexander; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2017-04-19       Impact factor: 7.329

6.  Birthweight in infants conceived through in vitro fertilization following blastocyst or cleavage-stage embryo transfer: a national registry study.

Authors:  Julia F Litzky; Sheree L Boulet; Navid Esfandiari; Yujia Zhang; Dmitry M Kissin; Regan N Theiler; Carmen J Marsit
Journal:  J Assist Reprod Genet       Date:  2018-04-10       Impact factor: 3.412

Review 7.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

8.  Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer.

Authors:  Cynthia K Sites; Sophia Bachilova; Daksha Gopal; Howard J Cabral; Charles C Coddington; Judy E Stern
Journal:  Am J Obstet Gynecol       Date:  2021-04-21       Impact factor: 10.693

9.  Assisted Reproductive Technology and Newborn Size in Singletons Resulting from Fresh and Cryopreserved Embryos Transfer.

Authors:  Galit Levi Dunietz; Claudia Holzman; Yujia Zhang; Nicole M Talge; Chenxi Li; David Todem; Sheree L Boulet; Patricia McKane; Dmitry M Kissin; Glenn Copeland; Dana Bernson; Michael P Diamond
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

10.  Genome-wide microRNA expression profiling in placentae from frozen-thawed blastocyst transfer.

Authors:  Hitoshi Hiura; Hiromitsu Hattori; Norio Kobayashi; Hiroaki Okae; Hatsune Chiba; Naoko Miyauchi; Akane Kitamura; Hiroyuki Kikuchi; Hiroaki Yoshida; Takahiro Arima
Journal:  Clin Epigenetics       Date:  2017-08-03       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.